Evaluation of the EMulate Therapeutics Voyager's ultra-low radiofrequency energy in murine model of glioblastoma.

Rajesh MukthavaramPengfei JiangSandra PastorinoNatsuko NomuraFeng LinSantosh Kesari

Published in: Bioelectronic medicine (2024)

The EMulate Therapeutics Voyager® demonstrates promising potential in inhibiting glioma cells in vivo through its unique ulRFE technology and should be further studied in terms of biological effects in vitro and in vivo.

Keyphrases

small molecule
signaling pathway
high resolution
catheter ablation
atrial fibrillation
climate change